濟南高新(600807.SH):擬掛牌轉讓翡翠房地產35%股權
格隆匯5月20日丨濟南高新(600807.SH)公佈,公司目前正聚焦生命健康園區開發運營和實業運營業務,推動公司積極轉型。根據公司發展戰略需要,為優化資源配置,根據前期合作協議約定,結合項目實際情況,永安房地產擬退出臨沂沂河傳奇項目後續開發事項。公司於2022年5月20日召開第十屆董事會第二十八次臨時會議,審議通過《關於審議公司全資子公司擬掛牌轉讓臨沂翡翠房地產開發有限公司35%股權的議案》,同意永安房地產通過山東產權交易中心公開掛牌轉讓翡翠房地產35%股權,根據評估結果,掛牌底價為5669.16萬元。同時授權經營層全權辦理本次公開掛牌轉讓的所有事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.